Untangling Macropore Formation and Current Facilitation in P2X7

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jul 14

PMID 37446075

Authors

Federico Cevoli

Benoit Arnould

Francisco Andres Peralta

Thomas Grutter

Affiliations

Soon will be listed here.

Abstract

Macropore formation and current facilitation are intriguing phenomena associated with ATP-gated P2X7 receptors (P2X7). Macropores are large pores formed in the cell membrane that allow the passage of large molecules. The precise mechanisms underlying macropore formation remain poorly understood, but recent evidence suggests two alternative pathways: a direct entry through the P2X7 pore itself, and an indirect pathway triggered by P2X7 activation involving additional proteins, such as TMEM16F channel/scramblase. On the other hand, current facilitation refers to the progressive increase in current amplitude and activation kinetics observed with prolonged or repetitive exposure to ATP. Various mechanisms, including the activation of chloride channels and intrinsic properties of P2X7, have been proposed to explain this phenomenon. In this comprehensive review, we present an in-depth overview of P2X7 current facilitation and macropore formation, highlighting new findings and proposing mechanistic models that may offer fresh insights into these untangled processes.

Citing Articles

Microglia-induced neuroinflammation in hippocampal neurogenesis following traumatic brain injury.

Navabi S, Badreh F, Khombi Shooshtari M, Hajipour S, Vastegani S, Khoshnam S Heliyon. 2024; 10(16):e35869.

PMID: 39220913 PMC: 11365414. DOI: 10.1016/j.heliyon.2024.e35869.

The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy.

Thakku Sivakumar D, Jain K, Alfehaid N, Wang Y, Teng X, Fischer W Int J Mol Sci. 2024; 25(13).

PMID: 39000004 PMC: 11241490. DOI: 10.3390/ijms25136894.

Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.

Al-Aqtash R, Collier D Channels (Austin). 2024; 18(1):2355150.

PMID: 38762911 PMC: 11110710. DOI: 10.1080/19336950.2024.2355150.

Purine and purinergic receptors in health and disease.

Ai Y, Wang H, Liu L, Qi Y, Tang S, Tang J MedComm (2020). 2023; 4(5):e359.

PMID: 37692109 PMC: 10484181. DOI: 10.1002/mco2.359.

References

Cheewatrakoolpong B, Gilchrest H, Anthes J, Greenfeder S . Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem Biophys Res Commun. 2005; 332(1):17-27. DOI: 10.1016/j.bbrc.2005.04.087. View

Roger S, Pelegrin P, Surprenant A . Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J Neurosci. 2008; 28(25):6393-401. PMC: 6670894. DOI: 10.1523/JNEUROSCI.0696-08.2008. View

Harkat M, Peverini L, Cerdan A, Dunning K, Beudez J, Martz A . On the permeation of large organic cations through the pore of ATP-gated P2X receptors. Proc Natl Acad Sci U S A. 2017; 114(19):E3786-E3795. PMC: 5441707. DOI: 10.1073/pnas.1701379114. View

Allsopp R, Evans R . Contribution of the Juxtatransmembrane Intracellular Regions to the Time Course and Permeation of ATP-gated P2X7 Receptor Ion Channels. J Biol Chem. 2015; 290(23):14556-66. PMC: 4505523. DOI: 10.1074/jbc.M115.642033. View

Ryoden Y, Nagata S . The XK plasma membrane scramblase and the VPS13A cytosolic lipid transporter for ATP-induced cell death. Bioessays. 2022; 44(10):e2200106. DOI: 10.1002/bies.202200106. View

Cankurtaran-Sayar S, Sayar K, Ugur M . P2X7 receptor activates multiple selective dye-permeation pathways in RAW 264.7 and human embryonic kidney 293 cells. Mol Pharmacol. 2009; 76(6):1323-32. DOI: 10.1124/mol.109.059923. View

Li M, Toombes G, Silberberg S, Swartz K . Physical basis of apparent pore dilation of ATP-activated P2X receptor channels. Nat Neurosci. 2015; 18(11):1577-83. PMC: 5113834. DOI: 10.1038/nn.4120. View

Pelegrin P, Surprenant A . Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 2006; 25(21):5071-82. PMC: 1630421. DOI: 10.1038/sj.emboj.7601378. View

Lara R, Adinolfi E, Harwood C, Philpott M, Barden J, Di Virgilio F . P2X7 in Cancer: From Molecular Mechanisms to Therapeutics. Front Pharmacol. 2020; 11:793. PMC: 7287489. DOI: 10.3389/fphar.2020.00793. View

10.

Illes P . P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases. Int J Mol Sci. 2020; 21(17). PMC: 7504621. DOI: 10.3390/ijms21175996. View

11.

Kanellopoulos J, Delarasse C . Pleiotropic Roles of P2X7 in the Central Nervous System. Front Cell Neurosci. 2019; 13:401. PMC: 6738027. DOI: 10.3389/fncel.2019.00401. View

12.

Di Virgilio F . Purines, purinergic receptors, and cancer. Cancer Res. 2012; 72(21):5441-7. DOI: 10.1158/0008-5472.CAN-12-1600. View

13.

Lord B, Aluisio L, Shoblock J, Neff R, Varlinskaya E, Ceusters M . Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432. J Pharmacol Exp Ther. 2014; 351(3):628-41. DOI: 10.1124/jpet.114.218487. View

14.

Di Virgilio F, Schmalzing G, Markwardt F . The Elusive P2X7 Macropore. Trends Cell Biol. 2018; 28(5):392-404. DOI: 10.1016/j.tcb.2018.01.005. View

15.

Durner A, Durner E, Nicke A . Improved ANAP incorporation and VCF analysis reveal details of P2X7 current facilitation and a limited conformational interplay between ATP binding and the intracellular ballast domain. Elife. 2023; 12. PMC: 9859053. DOI: 10.7554/eLife.82479. View

16.

Giuliani A, Colognesi D, Ricco T, Roncato C, Capece M, Amoroso F . Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. PLoS One. 2014; 9(9):e107224. PMC: 4165768. DOI: 10.1371/journal.pone.0107224. View

17.

Mansoor S, Lu W, Oosterheert W, Shekhar M, Tajkhorshid E, Gouaux E . X-ray structures define human P2X(3) receptor gating cycle and antagonist action. Nature. 2016; 538(7623):66-71. PMC: 5161641. DOI: 10.1038/nature19367. View

18.

Amadio S, Parisi C, Piras E, Fabbrizio P, Apolloni S, Montilli C . Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis. Front Immunol. 2017; 8:1529. PMC: 5694754. DOI: 10.3389/fimmu.2017.01529. View

19.

Nagata S, Suzuki J, Segawa K, Fujii T . Exposure of phosphatidylserine on the cell surface. Cell Death Differ. 2016; 23(6):952-61. PMC: 4987739. DOI: 10.1038/cdd.2016.7. View

20.

Riedel T, Schmalzing G, Markwardt F . Influence of extracellular monovalent cations on pore and gating properties of P2X7 receptor-operated single-channel currents. Biophys J. 2007; 93(3):846-58. PMC: 1913143. DOI: 10.1529/biophysj.106.103614. View